#ThinkSabio Latest News
Windtree Receives Non-Binding Letter Of Intent To Purchase Its Preclinical Oncology Drug Candidate For $7M Up Front And Up To $130M In Milestones With Up To $1.5B In Royalties
Windtree Receives Non-Binding Letter Of Intent To Purchase Its Preclinical Oncology Drug Candidate For $7M Up Front And Up To $130M In Milestones With Up To $1.5B In Royalties